Crocs (CROX) Tops Q4 EPS by 40c, Offers Guidance
Get Alerts CROX Hot Sheet
Price: $114.81 -2.31%
Revenue Growth %: +0.4%
Financial Fact:
Income (loss) from operations: -1.22M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +0.4%
Financial Fact:
Income (loss) from operations: -1.22M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Crocs (NASDAQ: CROX) reported Q4 EPS of $2.65, $0.40 better than the analyst estimate of $2.25. Revenue for the quarter came in at $945.2 million versus the consensus estimate of $935.01 million.
GUIDANCE:
Crocs sees Q1 2023 EPS of $2.06-$2.19, versus the consensus of $2.02.
- Revenues to grow approximately 27% to 30% compared to first quarter 2022 revenues of $660.1 million.
Crocs sees FY2023 EPS of $11.00-$11.31, versus the consensus of $10.86. Crocs sees FY2023 revenue of $3.9-4.0 billion, versus the consensus of $3.97 billion.
For earnings history and earnings-related data on Crocs (CROX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- GE Aerospace to acquire Consolidated Precision in $11.75b deal
- ASP Isotopes holds first capital markets day, targets $300M EBITDA by 2031
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share